Mr. Venkatesan Karaiyalan has been appointed as Head of Finance for Wellesta Healthcare Pvt. Ltd., India and Financial Process Excellence Lead for Wellesta Group in areas like enrichment of Technical Accounting Principles and System Lead. He is a Business-Finance Leader with multi-faceted experience in Top Global & Indian Organisations like Novartis, Danaher Corporation, CMA CGM, Sresta - 24 Mantra.

Prior to joining Wellesta, Mr. Karaiyalan worked as Chief Financial Officer at Sresta Natural Bio Products Pvt. Ltd. (24 Mantra) where he guided Business Strategy & Performance, monitored Financial Performance, Working capital, Cash-flows , Compliances and P&L growth.

His career spans over 28 years with comprehensive experience in various leadership roles and headed multi-locational Operations in diverse verticals like FMCG, Pharmaceuticals, Medical Devices, Test & Measuring Equipments, Global Captive Logistics BPOs, Consumer Durables.

He comes with extensive experience in Business Accounting, FP&A (Financial Planning & Analysis), Treasury, Taxation, Risk Mitigation, Governance & Compliance, Cross-Functional Team Leadership & Stakeholder Management. He brings a holistic view of Businesses and Strong Business Ethics.

Mr. Venkatesan Karaiyalan is a Chartered Accountant (ICAI- India) and holds a Master of Commerce degree from Madurai Kamaraj University, Tamil Nadu.

We see good opportunities in Indian Healthcare markets and opportunities for Wellesta to grow and show strong progress. We are sure that Mr. Venkatesan Karaiyalan’s experience will help our India business plan to achieve our vision and mission in India. He will report to Mr. Ashish Srivastava, Country Head, Wellesta India.

We welcome Mr. Venkatesan Karaiyalan to our Wellesta family and wish him great success in his new position.

Mr. Ashish Srivastava has been appointed as Country Head for India business and also to the Wellesta India Board of Directors with effect from January 15th, 2024.

Ashish is a seasoned player with extensive experience of 27 years in building brands, turning around & scaling up businesses. Prior to joining Wellesta, he was a Global Head for Orthopaedic Business for Biotech Healthcare Limited.

Ashish started his career with Johnson & Johnson and was associated with organisations like Allergan, Becton Dickinson, Intas Pharmaceuticals & Zydus Healthcare. He worked as Business Head (Ophthalmology) for Zydus Healthcare before he forayed in International Operations with Biotech Healthcare Limited. His core experience has been in Medical Devices, Ophthalmology & Orthopaedics lately.

Ashish holds Honours degree in Botanical Sciences from Delhi University and PGDBM from MDI, Gurgaon along with a two-year Executive course from IIM Ahmedabad.

We at Wellesta are very optimistic about Indian Healthcare market & opportunities for Wellesta to progress. We are sure that Ashish’s experience and leadership will help achieve our vision and mission in India. He will report to Milan Paleja, Chairman and MD of Wellesta Group.

We welcome Mr. Ashish Srivastava to the Wellesta family and wish him great success in this new position.

We are pleased to announce the appointment of Ms. Kanchan Agarwal as Manager, Finance with effect from 3rd May, 2021.

She has completed her CA from Institute of Chartered Accountants of India.

Kanchan brings about 10+ years of experience and has worked in Budgeting, Mis, Finance, Accounting, Audit, SAP Implementation, Compliance, Policies & Process Improvements. She earlier worked with Piramal Foundation, Voltas Ltd. (A Tata Enterprise), Tata Institute of Social Sciences and Pravin Navandar & Co.

She will be responsible for the entire finance function for India entity. She will give 75% of her time to India Business, for which she will report to Mr. Ravinder Kumar Sagar-CEO & Country Head.

She will also be supporting our HQ for 25% of time, for which she will be reporting to Mr. Milan Paleja-Chairman & Managing Director. She will be based at Mumbai Head Office.

Please join us in welcoming Kanchan to the Wellesta family. Wishing her the very best for a long and successful career with Wellesta.

Prior to joining Wellesta, Ms. Prinka worked with Naari Pharma (a Tenshi Group of Lifesciences’ company) as Senior Manager, Business Development for other regulated markets, emerging markets and global strategic accounts. Her career spans over 10 years of comprehensive experience in International Business Development for regulated markets like Europe, Australia & NZ, Canada and emerging markets. Ms. Prinka has handled multiple roles in her previous assignments including project management, portfolio designing and leading key launches in various markets under the larger role of business development.

She started her career from Strides Pharma as an executive in business development for domestic division and moved on to international business development in subsequent roles. She has also worked for a brief period at Biocon Ltd. as an International Marketing Executive for API Division - APAC and South Africa markets.

Ms. Prinka Mittal pursued her B.Pharm and MBA from Narsee Monjee Institute of Management Studies (NMIMS) Mumbai.

We are sure that Ms Mittal's rich experience and leadership will support us achieve our vision and mission. She will report to Milan Paleja, Chairman and MD of the Wellesta Group.

We welcome Ms. Prinka Mittal to the Wellesta family and wish her great success.

Wellesta Holdings Pte.Ltd is pleased to announce strategic alliance in India with Parazelsus through its subsidiary company in India, Wellesta Healthcare Pvt. Ltd.

Parazelsus is an MNC company founded by Peter Zuellig in 2007 and operates in multiple countries including India, specializing in Distribution & Logistics. The Company is led by Markus Haefeli as Managing Director. Parazelsus India with its focus on Distribution and Logistics in the Healthcare sector, decided to partner with Wellesta in India for its CSO & Sales and Marketing business.

Wellesta’s core strength is Marketing, Brand Management, Sales & Operations with world class standards in its business approach and compliance. We foresee this partnership will make a Perfect Fit by offering an end-to-end business solution to business partners. With this decision 120 employees have moved from Parazelsus to Wellesta in India.

This will help us achieve our goal to provide high quality end to end professional services and support while providing high quality healthcare products at optimum prices, to support improving health for patients. Our focus would be driven through our dedicated efforts, strong in-market experience, determination and commitment.

We are pleased to announce that . Prameet K Shah has joined us as Manager- Technical Operations. He will be reporting to Mr. Dinesh Nair - Director- Supply Chain and will be based at Head Office.

He has completed his M.Pharm from Poona College of Pharmacy – Pune and Executive MBA from ITM Mumbai.

He brings about 30+ years of experience in Planning, cross-functional coordination, production and product supply management, New Products sourcing, Pricing, costing and negotiations ,procurement management, Business development for contract manufacturing and earlier worked for Neon laboratories Ltd, Themis Medicare Ltd, Arvind Remedies Ltd, Unimark Remedies Ltd, Mission Vivacare Ltd, JB Chemicals, VHB Life science and Novartis India Ltd.

Please join us in welcoming Prameet to the Wellesta family. Wishing him the very best for a long and fruitful career with Wellesta.

We are pleased to announce the appointment of Ms. Kiran Alva as Manager, HR.

She has completed her MBA from H.K Institute of Management Studies & Research through Mumbai University and Master in labour Management from Annamalai University.

She brings about 8.5 years of experience in pharmaceuticals industries and Handled role ranging from Talent acquisition, Employee Engagement, Formulating Job Description & Recruitment Rules, KPI setting, and Performance Management Process.

She has earlier worked for Elder Health Care Ltd. (Elder Pharmaceutical Division). Fullife Health Care Pvt. Ltd, Regaliz Medicare Ltd and Eurolife Health Care Pvt.Ltd.

We welcome Ms. Kiran Alva to our Wellesta family and wish her great success in this role.

Mr. Kamal Anand has been appointed Director, Sales for India business with effect from 1st December, 2019. Mr. Anand is a competent professional with over 35 years of experience in Strategic Planning, Sales & Marketing and Business Development. In his last role, he was BU Head, Consumer Products Divison at Plethico Pharmaceuticals Ltd.

He possesses a strong leadership record and has a deep understanding of the consumer and business landscape across geographies having worked in the FMCG and Healthcare sector both in India and abroad. He started his career after his MBA as a Management Trainee in Ranbaxy, and later worked in DFM Foods, Dabur, Novartis and Plethico.

Mr. Anand holds an undergraduate and post graduate degree in Life Sciences as well as LLB degree from Delhi University and an MBA from Jodhpur University.

We at Wellesta are very optimistic about the opportunities in Indian Healthcare Market & opportunities for Wellesta to grow & make strong progress. We are sure that Mr. Anand's rich experience & leadership will help us to achieve our Vision & Mission in India.

Mr. Anand will report to Milan Paleja, Director of Wellesta Healthcare India & also Chairman & MD of the Wellesta Group.

We welcome Mr. Kamal Anand, who is originally from Delhi and is now based in Mumbai, to our Wellesta family. He will lead Sales Organisation & be a part of India Leadership team.

Mr. Sharad Virmani has been appointed as Director, Partner Business for Wellesta Healthcare Pvt. Ltd with effect from 1st February, 2020. Mr. Virmani is a very well-rounded professional with over 35 years of experience in Pharma, Capital Equipment, Medical Devices, Diagnostics, Surgical & Healthcare in MNC & Indian Companies. In his last role, he was Country Head and Business Director - South Asia for Sales, Marketing & Contract Sales Operations at Parazelsus Pte Ltd.

His experience in business spans over Pan-India, Bangladesh and Nepal for both MNC’s and Indian Companies. It encompasses of setting up and managing Contract Sales Operations & New Business Divisions with exposure to handling multiple therapeutic segments.

His career started as a Medical Representative at Serdia and Hoechst (Sanofi) and later worked with Torrent, AstraZeneca, Nicholas Piramal, Micro – BAL, Pharmalink (Invida), Comed and Parazelsus.

Mr. Virmani is a Science Graduate from Kanpur University and has a Diploma in Export Management from Indian Institute of Export Management.

We at Wellesta are very optimistic about opportunities in the Indian Healthcare Market & opportunities for Wellesta to grow and make strong progress. We are sure that Mr. Virmani's rounded experience & leadership will help to achieve our Vision & Mission in India.

Mr. Virmani will report to Milan Paleja, Director of Wellesta Healthcare India & also Chairman & MD of the Wellesta Group.

We welcome Mr. Sharad Virmani, originally from Delhi who is now based in Mumbai, to our Wellesta family and we look forward for him to make our company reach greater heights with his contribution.

Mr. Dinesh Nair has been appointed as Director, Supply Chain for Wellesta Healthcare Pvt. Ltd with effect from 1st December, 2019. Mr. Nair is a seasoned business leader with over 35 years of experience in Pharmaceutical, OTC, Medical Nutrition & Food Industry locally & internationally. He was previously Managing Partner at Integratos India LLP, India.

His experience in business spans over Asia Pacific and Africa for both MNC’s and Indian Companies. It encompasses the setting-up of new businesses, opening-up new Emerging markets, turning around under-performing businesses, establishing sales & distribution networks, managing P & L and leading cross-cultural & cross- functional teams across geographies.

His career started as Distribution Manger at Themis Pharmaceuticals and Medley Pharma later worked at First Arabian department stores, Novartis, Nestle, Equant Consultants Pvt. Ltd and Integratos India LLP.

Mr. Nair completed his post graduate diploma in Marketing & Sales Management and Computer Applications. He has obtained a Bachelor degree in Science from Mumbai University, India.

We at Wellesta are very optimistic about opportunities in Indian Healthcare Market & opportunities for Wellesta to grow & make strong progress. We are sure that Mr. Nair's experience & leadership will help to achieve our Vision & Mission in India.

Mr. Nair will report to Milan Paleja, Director of Wellesta Healthcare India & also Chairman & MD of the Wellesta Group.

We welcome Mr. Dinesh Nair, a Keralite who is now based in Mumbai, to our Wellesta family and wish him great success in his future endeavours.